https://www.dicotpharma.com/ 2026-03-31T12:09:59.48Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/ 2025-10-23T11:18:31.647Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/ 2025-10-23T13:45:31.38Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/tidig-forskning/ 2025-02-19T08:01:07.33Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/processutveckling-och-tillverkning/ 2025-02-19T08:04:57.067Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/farmakologistudier/ 2025-02-19T07:37:02.41Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/toxikologi/ 2025-02-19T07:38:28.437Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/klinisk-fas-1-studie/ 2025-02-19T07:41:59.4Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/klinisk-fas-1-studie/guide-till-de-kliniska-faserna/ 2025-02-04T12:11:54.977Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/kliniska-fas-2-studier/ 2025-11-24T09:25:59.69Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/lakemedelskandidaten-lib-01/verkningsmekanismen/ 2025-12-10T09:21:38.877Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/om-sexuella-dysfunktioner/ 2025-02-19T07:45:58.273Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/om-sexuella-dysfunktioner/erektil-dysfunktion/ 2025-02-19T08:10:06.263Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/om-sexuella-dysfunktioner/tidig-utlosning/ 2025-02-19T08:13:22.247Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/om-sexuella-dysfunktioner/kombination-av-sexuella-dysfunktioner/ 2025-02-19T08:14:38.403Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/marknadsbeskrivning/ 2025-08-20T13:09:50.04Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/marknadsbeskrivning/marknaden-for-erektil-dysfunktion/ 2025-08-28T11:45:10.757Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/marknadsbeskrivning/marknaden-for-tidig-utlosning/ 2025-02-19T10:03:05.76Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/patent/ 2025-11-25T14:05:27.843Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/publikationer/ 2025-03-04T17:17:52.38Z 0.5 https://www.dicotpharma.com/lakemedelsprojektet/radgivande-expertgrupp/ 2025-02-19T08:52:13.103Z 0.5 https://www.dicotpharma.com/om-dicot-pharma/ 2025-10-23T14:56:43.717Z 0.5 https://www.dicotpharma.com/om-dicot-pharma/affarside-strategi-vision/ 2025-02-19T10:07:07.807Z 0.5 https://www.dicotpharma.com/om-dicot-pharma/ledning/ 2026-03-05T08:11:06.06Z 0.5 https://www.dicotpharma.com/om-dicot-pharma/styrelse/ 2026-03-05T08:16:37.16Z 0.5 https://www.dicotpharma.com/om-dicot-pharma/bakgrund/ 2025-02-19T09:57:48.473Z 0.5 https://www.dicotpharma.com/om-dicot-pharma/kontakt/ 2026-03-05T08:32:33.327Z 0.5 https://www.dicotpharma.com/media/ 2025-03-17T16:24:40.143Z 0.5 https://www.dicotpharma.com/media/artiklar/ 2025-02-13T12:22:57.703Z 0.5 https://www.dicotpharma.com/media/filmer/ 2025-02-18T15:03:26.74Z 0.5 https://www.dicotpharma.com/media/poddar/ 2025-02-13T12:23:25.943Z 0.5 https://www.dicotpharma.com/media/dicotnytt/ 2025-02-14T11:18:47.693Z 0.5 https://www.dicotpharma.com/media/natives/viagraexpert-ett-potentiellt-paradigmskifte/ 2025-02-20T13:18:45.587Z 0.5 https://www.dicotpharma.com/media/natives/dicot-pharma-in-pa-nasdaq-first-north/ 2025-02-20T13:18:59.297Z 0.5 https://www.dicotpharma.com/media/natives/dicot-pharma-mot-proof-of-concept/ 2025-02-20T13:19:10.083Z 0.5 https://www.dicotpharma.com/media/natives/potenslakemedelsutvecklaren-dicot-pharma-i-expansion/ 2025-02-20T13:19:19.443Z 0.5 https://www.dicotpharma.com/media/natives/kliniskt-genombrott-for-potenslakemedelskandidat/ 2025-02-20T13:19:28.867Z 0.5 https://www.dicotpharma.com/media/natives/hon-ska-oka-den-sexuella-halsan-i-varlden/ 2025-02-20T13:19:42.273Z 0.5 https://www.dicotpharma.com/media/natives/att-behova-planera-sexlivet-tar-dod-pa-spontaniteten/ 2025-02-20T13:20:06.583Z 0.5 https://www.dicotpharma.com/media/natives/ljusning-for-behandling-av-erektionsproblem/ 2025-02-20T13:20:17.613Z 0.5 https://www.dicotpharma.com/media/natives/skamfyllt-men-vanligt-med-erektionsproblem-hos-unga-man/ 2025-02-20T13:20:26.537Z 0.5 https://www.dicotpharma.com/media/natives/uppstickaren-ska-utmana-potensmarknaden-med-nytt-langtidsverkande-lakemedel/ 2025-02-21T10:19:01.21Z 0.5 https://www.dicotpharma.com/press/ 2026-03-05T08:39:43.757Z 0.5 https://www.dicotpharma.com/press/pressmeddelanden/ 2025-03-07T09:21:38.587Z 0.5 https://www.dicotpharma.com/press/pressbilder/ 2025-12-11T14:21:36.74Z 0.5 https://www.dicotpharma.com/investor-relations/ 2026-03-05T08:43:27.047Z 0.5 https://www.dicotpharma.com/investor-relations/aktien/ 2026-02-04T11:35:53.197Z 0.5 https://www.dicotpharma.com/investor-relations/aktien/aktieagare/ 2025-02-19T10:41:06.587Z 0.5 https://www.dicotpharma.com/investor-relations/aktien/handelsinformation/ 2026-02-04T11:36:37.437Z 0.5 https://www.dicotpharma.com/investor-relations/aktien/aktiekapitalets-utveckling/ 2025-05-07T13:25:36.62Z 0.5 https://www.dicotpharma.com/investor-relations/bolagsstyrning/ 2026-03-05T08:46:46.787Z 0.5 https://www.dicotpharma.com/investor-relations/bolagsstyrning/revisor/ 2026-03-05T08:49:16.95Z 0.5 https://www.dicotpharma.com/investor-relations/bolagsstyrning/arsstamma-2026/ 2026-04-02T11:07:23.587Z 0.5 https://www.dicotpharma.com/investor-relations/bolagsstyrning/tidigare-stammor/ 2026-01-14T14:34:28.83Z 0.5 https://www.dicotpharma.com/investor-relations/bolagsstyrning/valberedning/ 2025-10-30T16:49:20.193Z 0.5 https://www.dicotpharma.com/investor-relations/bolagsstyrning/bolagsordning/ 2025-02-19T11:42:51.417Z 0.5 https://www.dicotpharma.com/investor-relations/bolagsstyrning/uppforandekod/ 2025-04-25T16:20:52.553Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/ 2025-02-03T11:30:40.243Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/finansiella-rapporter/ 2025-06-26T10:03:28.697Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/ 2025-04-25T11:50:10.343Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/teckningsoptioner-to6-2025/ 2025-05-07T15:48:17.09Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/foretradesemission-2024/ 2025-02-19T12:57:20.027Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/teckningsoptioner-to5-2023/ 2025-02-19T18:26:13.87Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/teckningsoptioner-to4-2023/ 2025-02-19T18:15:44.497Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/foretradesemission-2023/ 2025-02-19T18:29:15.99Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/teckningsoptioner-to3-2022/ 2025-02-19T17:47:44.87Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/foretradesemission-2021/ 2025-02-19T17:42:48.34Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/teckningsoptioner-to2-2021/ 2025-02-19T17:33:18.457Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/foretradesemission-2020/ 2025-02-19T17:30:05.877Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-emissioner/teckningsoptioner-to1-2020/ 2025-02-19T17:16:11.203Z 0.5 https://www.dicotpharma.com/investor-relations/rapporter-och-emissioner/tidigare-erbjudandehandlingar/ 2025-02-17T15:22:13.947Z 0.5 https://www.dicotpharma.com/investor-relations/finansiell-kalender-och-event/ 2025-02-19T13:10:21.027Z 0.5 https://www.dicotpharma.com/investor-relations/analyser/ 2025-08-26T14:36:24.287Z 0.5 https://www.dicotpharma.com/investor-relations/prenumerera/ 2025-06-26T10:16:03.137Z 0.5 https://www.dicotpharma.com/integritet/ 2025-02-15T15:57:39.047Z 0.5